Atia Vision is an ophthalmic medical device R&D manufacturer, affiliated to Shifamed, a Silicon Valley medical innovation incubator. The company focuses on the R&D and production of medical devices in the ophthalmic field, and develops safe and controllable presbyopia correction intraocular lenses to improve the treatment effect of patients. Restoring full range of functional vision in cataract patients. Atia Vision announced the completion of $42 million in Series E financing. The round was led by Cormorant Asset Management with participation from The Capital Partnership (TCP), PA MedTech VC Fund, AMED Ventures and Shifamed angel investors.
This article is reproduced from: https://www.itjuzi.com/investevent/13451585
This site is for inclusion only, and the copyright belongs to the original author.